The aim of this study was to estimate the accuracy of non-invasive fetal DS detection using tissue specific-methylation in PDE9A and to evaluate the potential of PDE9A as a new biomarker for the first trimester detection of fetal DS. The gene discussed is PDE9A; the disease is Dravet syndrome.